NextCure, Inc.
NXTC
$12.20
$0.241.97%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 12.69M | 13.29M | 14.21M | 15.08M | 15.72M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 57.62M | 60.31M | 63.86M | 53.07M | 57.21M |
| Operating Income | -57.62M | -60.31M | -63.86M | -53.07M | -57.21M |
| Income Before Tax | -55.84M | -58.01M | -60.93M | -49.52M | -55.65M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -55.84 | -58.01 | -60.93 | -49.52 | -55.65 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -55.84M | -58.01M | -60.93M | -49.52M | -55.65M |
| EBIT | -57.62M | -60.31M | -63.86M | -53.07M | -57.21M |
| EBITDA | -55.43M | -57.82M | -61.20M | -50.34M | -54.34M |
| EPS Basic | -21.58 | -24.19 | -25.91 | -21.23 | -23.89 |
| Normalized Basic EPS | -13.49 | -15.12 | -16.20 | -13.27 | -14.25 |
| EPS Diluted | -21.58 | -24.19 | -25.91 | -21.23 | -23.89 |
| Normalized Diluted EPS | -13.49 | -15.12 | -16.20 | -13.27 | -14.25 |
| Average Basic Shares Outstanding | 11.37M | 9.72M | 9.37M | 9.33M | 9.32M |
| Average Diluted Shares Outstanding | 11.37M | 9.72M | 9.37M | 9.33M | 9.32M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |